Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.32 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4201883 | 0.84 | — | — | |
| SCHEMBL5273818 | 0.84 | — | — | |
| SCHEMBL3672289 | 0.81 | EPHX1 (0.33) | — | |
| SCHEMBL9697701 | 0.78 | CYP2C19 (0.30) | CYP2C19 | |
| SCHEMBL9695712 | 0.77 | LMNA (0.31) | — | |
| SCHEMBL27991277 | 0.74 | LMNA (0.32) | GRM2GRM3CYP2C19 | |
| SCHEMBL1015563 | 0.74 | — | — | |
| SCHEMBL3725259 | 0.74 | EPHX1 (0.30) | — | |
| SCHEMBL230310 | 0.71 | — | — | |
| SCHEMBL9697374 | 0.70 | CYP1A2 (0.36) | CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008132128-A2 | SYNTHESIS OF A PHARMACEUTICALLY ACTIVE COMPOUND | Solvay (Société Anonyme) (BE) | 2008-11-06 | — | — | WO | claimed |
| EP-1985603-A1 | Process for preparing difluorocyclohexanoic acid derivatives | SOLVAY (Société Anonyme) (BE) | 2008-10-29 | — | — | EP | claimed |
| WO-2025024029-A1 | METAL ORGANIC RESIST PHOTOSENSITIVITY IMPROVEMENT USING CARBOXYLIC ACID | VERSUM MATERIALS US, LLC (US) | 2025-01-30 | — | — | WO | disclosed |
| WO-2023205463-A1 | HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-10-26 | — | — | WO | disclosed |
| US-20210289794-A1 | COMPOSITIONS AND RELATED METHODS FOR AGRICULTURE | FLAGSHIP PIONEERING INNOVATIONS V, INC. | 2021-09-23 | — | — | US | disclosed |
| EP-2694472-A2 | SULFONAMIDE DERIVATIVE AND USE THEREOF | Takeda Pharmaceutical Company Limited (JP) | 2014-02-12 | — | — | EP | disclosed |
| WO-2012137982-A9 | SULFONAMIDE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-02-14 | — | — | WO | disclosed |
| WO-2012137982-A2 | SULFONAMIDE DERIVATIVE AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-10-11 | — | — | WO | disclosed |
| US-20080312206-A1 | Chemical Compounds-149 | ASTRAZENECA AB (SE) | 2008-12-18 | — | — | US | disclosed |
| WO-2008132128-A2 | SYNTHESIS OF A PHARMACEUTICALLY ACTIVE COMPOUND | Solvay (Société Anonyme) (BE) | 2008-11-06 | — | — | WO | disclosed |
| EP-1985603-A1 | Process for preparing difluorocyclohexanoic acid derivatives | SOLVAY (Société Anonyme) (BE) | 2008-10-29 | — | — | EP | disclosed |
| EP-1985603-A1 | Process for preparing difluorocyclohexanoic acid derivatives | SOLVAY (Société Anonyme) (BE) | 2008-10-29 | — | — | EP | disclosed |
| EP-1985603-A1 | Process for preparing difluorocyclohexanoic acid derivatives | SOLVAY (Société Anonyme) (BE) | 2008-10-29 | — | — | EP | disclosed |
| EP-1963303-A2 | CHEMICAL COMPOUNDS | Pfizer Limited (GB) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007066201-A2 | CHEMICAL COMPOUNDS | PFIZER LIMITED (GB) | 2007-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312206-A1 | Chemical Compounds-149 | CSF3R, CSF1R, FLT3 | GRM2 1440/4885GRM3 1334/4885CYP2C19 3921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.